Skip to main content

OCA · NZX

Oceania Healthcare (OCA)

Healthcare / Retirement livingCovered: HY23 - HY267 published briefings

Oceania Healthcare is an NZX-listed healthcare / retirement living company. Its latest covered result is HY26, with HY23 - HY26 of source-backed result history on Annolyse.

Latest result

Latest metrics

HY26, released 21 November 2025

← Swipe to view more
OCA latest metrics
MetricValueChange
Revenue$131.6m↓ -0.7%
EBITDA$41.5m↑ +7.4%
NPAT$4.9m↑ +128.7%
Operating cash flow$79m↑ +12.3%
OCF / EBITDA %190.4%↑ +8.4pp
Net debt$608.9m↓ -3.2%
Net debt / EBITDA14.67x↓ -9.8%
ROE %0.4%↑ +2.0pp
PBT$1m↑ +105.1%
FCF pre-lease$25.9m↓ -37.2%

Source: latest published briefing (HY26, released 21 November 2025). Change compares against the prior equivalent period: HY25, released 22 November 2024.

Valuation

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$427.3m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

8.15x

i

Recent market cap compared with trailing earnings.

EPS

0.07

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

11.66x

i

Enterprise value compared with recent EBITDA.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

0.37x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Ask about OCA

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more
OCA metric history
MetricHY266 MONTHS21 November 2025FY2512 MONTHS22 May 2025HY256 MONTHS22 November 2024FY2412 MONTHS24 May 2024HY246 MONTHS22 November 2023FY2312 MONTHS24 May 2023HY236 MONTHS7 November 2022Trend
Revenue$131.6m$260.6m$132.6m$265.5m$131.6m$247.2m$122.1m
Chart
Revenue growth %-0.7%-1.8%0.8%7.4%—6.9%7.2%
Chart
EBITDA$41.5m$86m$38.6m$82.6m$37.6m$80m—
Chart
EBITDA margin %31.5%33.0%29.1%31.1%28.6%32.4%—
Chart
PBT$1m$25.9m-$19.5m$28.4m$32.4m$12m$8.6m
Chart
PBT growth %—————-78.7%-74.3%
Chart
NPAT$4.9m$30.4m-$17.1m$31.5m$35.2m$15.4m$11.2m
Chart
NPAT growth %—-3.5%—104.5%—-74.8%-69.6%
Chart
Operating cash flow$79m$110.3m$70.4m$85.4m$48m$70.2m$31.4m
Chart
OCF / EBITDA %190.4%128.3%182.0%103.3%127.6%87.7%—
Chart
FCF pre-lease$25.9m-$22.1m$41.2m$33.4m—$15m-$4.5m
Chart
DPS—0.0c——0.0c—1.9c
Chart
Payout ratio vs NPAT %——————118.8%
—
ROE %0.4%2.8%-1.6%3.1%3.5%1.6%1.2%
Chart
Net debt$608.9m$628m$628.9m$633m$611.1m$550.6m$497.6m
Chart
Net debt / EBITDA14.67x7.3x16.27x7.66x16.24x6.88x—
Chart
Debtor days29—28172168161130
Chart
Total assets$3b$2.9b$2.8b$2.8b$2.7b$2.5b$2.5b
Chart

Reference: annolyse.ai/companies/oca

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...

The setup & the reality

FY25 → HY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY25 said to watch

Previous analysisFY25Result releasedAnnolyse analysis published

From Capex jumped 354% to $132.4m, pushing FCF to -$22.1m

HY25 reported an NPAT loss of $17.1m and FY25 reported profit of $30.4m, implying H2 reported profit of $47.5m. Revenue split roughly 51%/49% and reported EBITDA45%/55% across H1/H2. The split does not identify the cause of the profit improvement or establish underlying momentum.

The release does not explain when the elevated capex translates to EBITDA. Without that bridge, the investor cannot judge whether FY26 EBITDA growth will be sufficient to bring leverage and free cash flow back into a more conventional range for the sector.

Open questions

Open questions from FY25

  • What share of the $132.4m capex was growth/development versus maintenance, and what new-unit settlement profile does it support in FY26 and FY27?
  • Why was the effective tax rate -17.8% in FY25, and is the tax credit recurring or one-off?
  • What is the path back to positive free cash flow and the conditions for reinstating dividends?
  • How much covenant headroom exists at 7.3x net debt/EBITDA, and what assumptions underpin that headroom?
  • Why did implied H2 operating cash inflow of around $40m run well below the H1 $70.4m, and is that a timing or a structural shift? The reported EBITDA arithmetic is a separate basis from underlying EBITDA.

This briefing cannot assess the unit economics of the development pipeline or the settlement timing that would determine when the FY25 capex starts generating returns.

Latest result sources

Primary issuer documents used for the HY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

1HY26 Interim Report

HY26 / financial report

1HY26 Investor Presentation

HY26 / results presentation

1HY26 Media Release

HY26 / media release

1HY26 Results Announcement

HY26 / results announcement

Prior comparable period

Full-year context

Release context

2025 ASM Chair Address

HY26 / commentary

Institutional Investor Day - Presentation

HY26 / commentary

Oceania Investor Day - 16 September 2025

HY26 / commentary

Peer context

Retirement living comparison set

These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.

Archive

Briefing archive

The full chronological archive contains every published result briefing.

Open all 7 result briefings

Get notified when OCA publishes

Get the next Oceania Healthcare result briefing and five-year history updates by email.